Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML

Por Borate, Uma, Absher, Devin, Erba, Harry P, Pasche, Boris
Publicado em 2012

Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia

Por Medeiros, Bruno C., Othus, Megan, Fang, Min, Appelbaum, Frederick R., Erba, Harry P.
Publicado no Haematologica (2015)

Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia

Por Othus, Megan, Wood, Brent L., Stirewalt, Derek L., Estey, Elihu H., Petersdorf, Stephen H., Appelbaum, Frederick R., Erba, Harry P., Walter, Roland B.
Publicado no Leukemia (2016)

A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia

Por Nand, Sucha, Othus, Megan, Godwin, John E., Willman, Cheryl L., Norwood, Thomas H., Howard, Dianna S., Coutre, Steven E., Erba, Harry P., Appelbaum, Frederick R.
Publicado em 2013

Safety and Pharmacokinetics of the Antisense Oligonucleotide (ASO) LY2181308 as a Single-Agent or in Combination with Idarubicin and Cytarabine in Patients with Refractory or Relap...

Por Erba, Harry P., Sayar, Hamid, Juckett, Mark, Lahn, Michael, Andre, Valerie, Callies, Sophie, Schmidt, Shelly, Kadam, Sunil, Brandt, John T., Van Bockstaele, Dirk, Andreeff, Michael
Publicado em 2013

In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

Por Minagawa, Kentaro, Jamil, Muhammad O., AL-Obaidi, Mustafa, Pereboeva, Larisa, Salzman, Donna, Erba, Harry P., Lamb, Lawrence S., Bhatia, Ravi, Mineishi, Shin, Di Stasi, Antonio
Publicado no PLoS One (2016)

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

Por Minagawa, Kentaro, Jamil, Muhammad O., AL-Obaidi, Mustafa, Pereboeva, Larisa, Salzman, Donna, Erba, Harry P., Lamb, Lawrence S., Bhatia, Ravi, Mineishi, Shin, Di Stasi, Antonio
Publicado no PLoS One (2017)

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

Por Walter, Roland B., Othus, Megan, Löwenberg, Bob, Ossenkoppele, Gert J., Petersdorf, Stephen H., Pabst, Thomas, Vekemans, Marie-Christiane, Appelbaum, Frederick R., Erba, Harry P., Estey, Elihu H.
Publicado no Haematologica (2015)

Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, in combination with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia - result...

Por DiPersio, John F., Erba, Harry P., Larson, Richard A., Luger, Selina M., Tallman, Martin S., Brill, Jeffrey M., Vuagniaux, Gregoire, Rouits, Elisabeth, Sorensen, J. Mel, Zanna, Claudio
Publicado no Clin Lymphoma Myeloma Leuk (2015)

Four Different Regimens of Farnesyltransferase Inhibitor Tipifarnib in Older, Untreated Acute Myeloid Leukemia Patients: North American Intergroup Phase II Study SWOG S0432

Por Erba, Harry P., Othus, Megan, Walter, Roland B., Kirschbaum, Mark H., Tallman, Martin S., Larson, Richard A., Slovak, Marilyn L., Kopecky, Kenneth J., Gundacker, Holly M., Appelbaum, Frederick R.
Publicado no Leuk Res (2013)

Comparison of the Prognostic Utility of the Revised International Prognostic Scoring System and the French Prognostic Scoring System in Azacitidine-Treated Patients with Myelodyspl...

Por Zeidan, Amer M, Lee, Ju-Whei, Prebet, Thomas, Greenberg, Peter, Sun, Zhuoxin, Juckett, Mark, Smith, Mitchell R, Paietta, Elisabeth, Gabrilove, Janice, Erba, Harry P, Tallman, Martin S., Gore, Steven D.
Publicado no Br J Haematol (2014)

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myelo...

Por Zeidan, Amer M, Lee, Ju-Whei, Prebet, Thomas, Greenberg, Peter, Sun, Zhuoxin, Juckett, Mark, Smith, Mitchell R, Paietta, Elisabeth, Gabrilove, Janice, Erba, Harry P, Tallman, Martin S., Gore, Steven D.
Publicado no Br J Haematol (2014)

Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients

Por Achille, Nicholas J., Othus, Megan, Phelan, Kathleen, Zhang, Shubin, Cooper, Kathrine, Godwin, John E., Appelbaum, Frederick R., Radich, Jerald P., Erba, Harry P., Nand, Sucha, Zeleznik-Le, Nancy J.
Publicado no Leuk Res (2016)

Sequential phase II Southwest Oncology Group studies (S0012 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with...

Por Chauncey, Thomas R., Gundacker, Holly, Shadman, Mazyar, List, Alan F., Dakhil, Shaker R., Erba, Harry P., Slovak, Marilyn L., Chen, I-Ming, Willman, Cheryl L., Kopecky, Kenneth J., Appelbaum, Frederick R.
Publicado em 2009

The Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy

Por Othus, Megan, Appelbaum, Frederick R., Petersdorf, Stephen H., Kopecky, Kenneth J., Slovak, Marilyn, Nevill, Thomas, Brandwein, Joseph, Larson, Richard A., Stiff, Patrick J., Walter, Roland B., Tallman, Martin S., Stenke, Leif, Erba, Harry P.
Publicado no Biol Blood Marrow Transplant (2014)

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

Por Petersdorf, Stephen H., Kopecky, Kenneth J., Slovak, Marilyn, Willman, Cheryl, Nevill, Thomas, Brandwein, Joseph, Larson, Richard A., Erba, Harry P., Stiff, Patrick J., Stuart, Robert K., Walter, Roland B., Tallman, Martin S., Stenke, Leif, Appelbaum, Frederick R.
Publicado em 2013

Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Por Prebet, Thomas, Sun, Zhuoxin, Ketterling, Rhett P., Zeidan, Amer, Greenberg, Peter, Herman, James, Juckett, Mark, Smith, Mitchell R., Malick, Lisa, Paietta, Elisabeth, Czader, Magdalena, Figueroa, Maria, Gabrilove, Janice, Erba, Harry P., Tallman, Martin S., Litzow, Mark, Gore, Steven D.
Publicado no Br J Haematol (2015)

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Le...

Por Prebet, Thomas, Sun, Zhuoxin, Figueroa, Maria E., Ketterling, Rhett, Melnick, Ari, Greenberg, Peter L., Herman, James, Juckett, Mark, Smith, Mitchell R., Malick, Lisa, Paietta, Elisabeth, Czader, Magdalena, Litzow, Mark, Gabrilove, Janice, Erba, Harry P., Gore, Steven D., Tallman, Martin S.
Publicado em 2014

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

Por Lindsley, R. Coleman, Mar, Brenton G., Mazzola, Emanuele, Grauman, Peter V., Shareef, Sarah, Allen, Steven L., Pigneux, Arnaud, Wetzler, Meir, Stuart, Robert K., Erba, Harry P., Damon, Lloyd E., Powell, Bayard L., Lindeman, Neal, Steensma, David P., Wadleigh, Martha, DeAngelo, Daniel J., Neuberg, Donna, Stone, Richard M., Ebert, Benjamin L.
Publicado no Blood (2015)

Wide Variations in Blood Product Transfusion Practices among Providers Who Care for Patients with Acute Leukemia in the United States

Por Pine, Alexander B, Lee, Eun-Ju, Sekeres, Mikkael, Steensma, David P, Zelterman, Daniel, Prebet, Thomas, DeZern, Amy, Komrokji, Rami, Litzow, Mark, Luger, Selina, Stone, Richard, Erba, Harry P, Garcia-Manero, Guillermo, Lee, Alfred I, Podoltsev, Nikolai A, Barbarotta, Lisa, Kasberg, Stephanie, Hendrickson, Jeanne E, Gore, Steven D, Zeidan, Amer M
Publicado no Transfusion (2016)